Syros Pharmaceuticals Inc.(SYRS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SYRS Syros Pharmaceuticals Inc.

已收盘 07-16 16:00:00 EDT

6.52

+0.38

+6.19%

盘后6.75

+0.23+3.59%

18:42 EDT

最高6.69	最低6.09	成交量8.71万
今开6.09	昨收6.14	日振幅9.77%
总市值1.74亿	流通市值8,198万	总股本2,673万
成交额56.77万	换手率0.69%	流通股本1,257万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SYRS","market":"US","secType":"STK","nameCN":"Syros Pharmaceuticals Inc.","latestPrice":6.52,"timestamp":1721160000000,"preClose":6.14,"halted":0,"volume":87104,"hourTrading":{"tag":"盘后","latestPrice":6.754,"preClose":6.52,"latestTime":"18:42 EDT","volume":2786,"amount":18206.65,"timestamp":1721169767523},"delay":0,"floatShares":12573234,"shares":26728337,"eps":-4.644623,"marketStatus":"已收盘","marketStatusCode":5,"change":0.38,"latestTime":"07-16 16:00:00 EDT","open":6.09,"high":6.69,"low":6.09,"amount":567743.349376,"amplitude":0.09772,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.644623,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721203200000},"adr":0,"listingDate":1467259200000,"adjPreClose":6.14,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":6.11,"preClose":6.14,"latestTime":"09:29 EDT","volume":100,"amount":611.5,"timestamp":1721136569018},"postHourTrading":{"tag":"盘后","latestPrice":6.754,"preClose":6.52,"latestTime":"18:42 EDT","volume":2786,"amount":18206.65,"timestamp":1721169767523},"volumeRatio":0.84722,"impliedVol":0.8201,"impliedVolPercentile":0.1151},"requestUrl":"/m/hq/s/SYRS","defaultTab":"news","newsList":[{"id":"2450580845","title":"Syros Pharmaceuticals, Inc.盘中异动 急速拉升5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450580845","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450580845?lang=zh_cn&edition=full","pubTime":"2024-07-11 00:49","pubTimestamp":1720630169,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日00时49分，Syros Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.42%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.14%。其相关个股中，Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Longeveron Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为3946.61%、1460.97%、1134.06%，振幅较大的相关个股有Kazia Therapeutics Limited、Revolution Medicines Inc C/Wts 17/12/2026 、Virpax Pharmaceuticals, Inc.，振幅分别为421.88%、133.16%、119.83%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110049299681b970&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110049299681b970&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRSW","SYRS","BK4139"],"gpt_icon":0},{"id":"2450020414","title":"Syros Pharmaceuticals, Inc.盘中异动 股价大涨5.02%报5.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450020414","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450020414?lang=zh_cn&edition=full","pubTime":"2024-07-10 00:31","pubTimestamp":1720542666,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日00时31分，Syros Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.02%。截至发稿，该股报5.44美元/股，成交量4.795万股，换手率0.18%，振幅5.75%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100031079681b31a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100031079681b31a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRSW","SYRS"],"gpt_icon":0},{"id":"2448823942","title":"Syros Pharmaceuticals, Inc.盘中异动 临近收盘急速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448823942","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448823942?lang=zh_cn&edition=full","pubTime":"2024-07-02 03:45","pubTimestamp":1719863122,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日03时45分，Syros Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.04%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。消息层面，截至03时45分，《Form 144 | Syros Pharmaceuticals董事拟出售3.48万股股份，价值约19.93万美元》资讯为影响Syros Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702034523af900c15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702034523af900c15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRSW","SYRS","BK4139"],"gpt_icon":0},{"id":"2446368516","title":"Syros Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446368516","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446368516?lang=zh_cn&edition=full","pubTime":"2024-06-28 22:00","pubTimestamp":1719583230,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日22时00分，Syros Pharmaceuticals, Inc.股票出现波动，股价快速下跌6.98%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。消息层面，截至22时00分，《JMP Securities维持Syros Pharmaceuticals买入评级，维持目标价12美元》资讯为影响Syros Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628220031aef72a5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628220031aef72a5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRS","SYRSW","BK4139"],"gpt_icon":0},{"id":"2443634238","title":"Syros Pharmaceuticals, Inc.盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443634238","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443634238?lang=zh_cn&edition=full","pubTime":"2024-06-14 01:51","pubTimestamp":1718301091,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日01时51分，Syros Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.19%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Longeveron Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、乌龙制药涨幅较大，Longeveron Inc.、Biorestorative Therapies, Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为2629.27%、1282.95%、148.31%，振幅较大的相关个股有Longeveron Inc.、Cero Therapeutics Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为102.21%、82.05%、74.62%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061401513196814100&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061401513196814100&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRS","SYRSW"],"gpt_icon":0},{"id":"2437435902","title":"Syros Pharmaceuticals, Inc.盘中异动 急速下挫5.04%报5.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437435902","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437435902?lang=zh_cn&edition=full","pubTime":"2024-05-23 04:00","pubTimestamp":1716408038,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日04时00分，Syros Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.04%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Effector Therapeutics Inc C/Wts 31/12/2025 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Gt Biopharma, Inc.较为活跃，换手率分别为365.05%、181.62%、61.00%，振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Mustang Bio, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为74.26%、65.74%、57.14%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523040038941e97a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523040038941e97a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRSW","SYRS"],"gpt_icon":0},{"id":"2436198415","title":"Syros Pharmaceuticals, Inc.2024财年第一财季实现净利润-3.71百万美元，同比增加84.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436198415","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436198415?lang=zh_cn&edition=full","pubTime":"2024-05-20 00:07","pubTimestamp":1716134845,"startTime":"0","endTime":"0","summary":"3月31日，Syros Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第一财季净利润为-3.71百万美元，同比增加84.41%；其中营业收入为0.00美元，每股基本收益为-0.10美元。机构评级：截至2024年3月31日，当前有4家机构对Syros Pharmaceuticals, Inc.目标价做出预测，其中目标均价为19.25美元，其中最低目标价为12.00美元，最高目标价为37.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405200007358b185ecc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405200007358b185ecc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRSW","SYRS"],"gpt_icon":0},{"id":"2435190535","title":"Syros Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.13%报5.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435190535","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435190535?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:43","pubTimestamp":1715694198,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时43分，Syros Pharmaceuticals, Inc.股票出现异动，股价快速上涨6.13%。截至发稿，该股报5.37美元/股，成交量7419股，换手率0.03%，振幅3.56%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421431887e87d02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421431887e87d02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRSW","SYRS"],"gpt_icon":0},{"id":"2434011595","title":"Syros Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434011595","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434011595?lang=zh_cn&edition=full","pubTime":"2024-05-09 23:02","pubTimestamp":1715266924,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日23时02分，Syros Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.00%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、再鼎医药、G1 Therapeutics, Inc.涨幅较大，Notable Labs, Ltd.、Allarity Therapeutics, Inc.、Cytomx Therapeutics, Inc.较为活跃，换手率分别为140.42%、111.48%、30.19%，振幅较大的相关个股有Notable Labs, Ltd.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、G1 Therapeutics, Inc.，振幅分别为57.24%、52.52%、40.79%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509230204861ec232&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509230204861ec232&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRSW","BK4139","SYRS"],"gpt_icon":0},{"id":"2422992673","title":"Syros Pharmaceuticals Inc 报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2422992673","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422992673?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:31","pubTimestamp":1711546290,"startTime":"0","endTime":"0","summary":"   * Syros Pharmaceuticals Inc   报告了截至12月底的季度调整后每股亏损2.18美元，低于去年同期的每股收益-17美分。五位分析师对该季度的平均预期是每股亏损 1.14 美元。华尔街预期为每股亏损 1.38 美元至-78 美分。* Syros Pharmaceuticals Inc 公布的本季度每股收益为亏损 2.18 美元。* 该公司的季度亏损额为 6438 万美元。* Syros Pharmaceuticals Inc 的股价本季度下跌了 19.8%。华尔街对 Syros Pharmaceuticals Inc 的 12 个月目标价中位数为 15.00 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SYRS"],"gpt_icon":0},{"id":"2422051139","title":"Syros Pharmaceuticals Inc    预计每股亏损 1.14 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2422051139","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422051139?lang=zh_cn&edition=full","pubTime":"2024-03-25 20:37","pubTimestamp":1711370258,"startTime":"0","endTime":"0","summary":"   * Syros Pharmaceuticals Inc    将于3月27日公布截至2023年12月31日的财报，预计该公司的季度收入将有所增长。* LSEG 分析师对 Syros Pharmaceuticals Inc 的平均预期是每股亏损 1.14 美元。* 华尔街对 Syros Pharmaceuticals Inc 的 12 个月目标价中位数为 15.00 美元，高于其最新收盘价 6.27 美元。3月25日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRS"],"gpt_icon":0},{"id":"2414580918","title":"Syros Pharmaceuticals Inc    预计每股亏损 1.14 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2414580918","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414580918?lang=zh_cn&edition=full","pubTime":"2024-02-27 23:25","pubTimestamp":1709047559,"startTime":"0","endTime":"0","summary":"   * Syros Pharmaceuticals Inc    预计在2月29日公布截至2023年12月31日的财报时，季度收入将有所增长(预计)    * 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于马萨诸塞州剑桥市的公司的营收有望从一年前的75.4万美元增至200万美元，增幅为165.3%。* LSEG 分析师对 Syros Pharmaceuticals Inc 的平均预期是每股亏损 1.14 美元。* 华尔街对 Syros Pharmaceuticals Inc 的 12 个月目标价中位数为 15.00 美元，高于其最新收盘价 7.49 美元。2月27日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.syros.com","stockEarnings":[{"period":"1week","weight":0.1853},{"period":"1month","weight":0.0233},{"period":"3month","weight":0.1043},{"period":"6month","weight":-0.1303},{"period":"1year","weight":0.8328},{"period":"ytd","weight":-0.2118}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0345},{"period":"3month","weight":0.1152},{"period":"6month","weight":0.189},{"period":"1year","weight":0.2498},{"period":"ytd","weight":0.1814}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Syros Pharmaceuticals, Inc.于2011年11月9日根据特拉华州法律注册成立。该公司是一家生物制药公司，致力于为血液系统恶性肿瘤患者的一线治疗制定新的护理标准。该公司正在推进一项后期临床计划，其中包括候选主要产品：（i）Tamibarotene，一种选择性视黄酸受体α激动剂，该公司正在进行SELECT-MDS-1，这是一项3期临床试验，评估达菲与阿扎胞苷联合治疗高危骨髓增生异常综合征（HR-MDS）患者的基因组定义子集。（ii）SY-2101，一种新的口服形式的三氧化二砷或ATO，其在新诊断的低风险急性早幼粒细胞白血病或APL患者的剂量确认研究中进行评估。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.008745},{"month":2,"riseRate":0.5,"avgChangeRate":-0.093448},{"month":3,"riseRate":0.5,"avgChangeRate":0.03661},{"month":4,"riseRate":0.375,"avgChangeRate":-0.022337},{"month":5,"riseRate":0.625,"avgChangeRate":0.031071},{"month":6,"riseRate":0.625,"avgChangeRate":0.041503},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.01533},{"month":8,"riseRate":0.75,"avgChangeRate":0.158103},{"month":9,"riseRate":0.25,"avgChangeRate":-0.10985},{"month":10,"riseRate":0.125,"avgChangeRate":-0.226094},{"month":11,"riseRate":0.375,"avgChangeRate":-0.005364},{"month":12,"riseRate":0.375,"avgChangeRate":0.20216}],"exchange":"NASDAQ","name":"Syros Pharmaceuticals Inc.","nameEN":"Syros Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.0","shortVersion":"4.25.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Syros Pharmaceuticals Inc.(SYRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Syros Pharmaceuticals Inc.(SYRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Syros Pharmaceuticals Inc.,SYRS,Syros Pharmaceuticals Inc.股票,Syros Pharmaceuticals Inc.股票老虎,Syros Pharmaceuticals Inc.股票老虎国际,Syros Pharmaceuticals Inc.行情,Syros Pharmaceuticals Inc.股票行情,Syros Pharmaceuticals Inc.股价,Syros Pharmaceuticals Inc.股市,Syros Pharmaceuticals Inc.股票价格,Syros Pharmaceuticals Inc.股票交易,Syros Pharmaceuticals Inc.股票购买,Syros Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Syros Pharmaceuticals Inc.(SYRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Syros Pharmaceuticals Inc.(SYRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}